Latest Breaking News On - Immune biosimilars today - Page 1 : vimarsana.com

Don't Mess with Success: U.S. Immunology Treaters Resistant to Switching Stable Humira Patients to Biosimilars, According to Spherix Global Insights

/PRNewswire/ Amgen launched the first U.S. adalimumab biosimilar, Amjevita, in January 2023. Yet according to the latest findings from Spherix Global.

Chrystal fergusonCoherus biosciencesMark cuban cost plus drug companySpherix networkSpherix global insightsSpecial topixImmune biosimilars todayGlobal insightsInsights director

Don't Mess with Success: U.S. Immunology Treaters Resistant to Switching Stable Humira Patients to Biosimilars, According to Spherix Global Insights

Don't Mess with Success: U.S. Immunology Treaters Resistant to Switching Stable Humira Patients to Biosimilars, According to Spherix Global Insights
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Scott uphamCoherus biosciencesChrystal fergusonMark cuban cost plus drug companyCorporate communicationsSpherix networkSpherix global insightsSpecial topixImmune biosimilars todayGlobal insightsInsights directorSpherix global insight